FBnTP Imaging of Breast Cancer
FBnTP Positron Emission Mammography Imaging of Mitochondria Function - Breast Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Terminated
Lock of funding
Other terminated trials from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Oligometastatic Disease · Apr 2026
- Systemic Sclerosis · Phase PHASE1 · Nov 2024
- Renal Cell Carcinoma Metastatic · Phase NA · Apr 2024
- Pancreas Cancer · Phase NA · Aug 2023
- Glioma, Malignant · Aug 2022
See all terminations from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Listed as NCT02204462, this PHASE1 trial focuses on Breast Cancer and remains terminated or withdrawn. Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, it has been updated 9 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2022 — Jul 2024 [monthly]
Terminated PHASE1
Status: Suspended → Terminated
-
Jan 2021 — Jan 2022 [monthly]
Suspended PHASE1
-
Jun 2020 — Jan 2021 [monthly]
Suspended PHASE1
▶ Show 4 earlier versions
-
Mar 2019 — Jun 2020 [monthly]
Suspended PHASE1
Status: Unknown Status → Suspended
-
Jun 2018 — Mar 2019 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
For direct contact, visit the study record on ClinicalTrials.gov .